Active surveillance (AS) following a complete clinical response to neoadjuvant chemoradiotherapy was noninferior to standard ...

Steven Richardson, after being diagnosed with stage 4 cancer of the esophagus in 2023, would have to split his focus between ...

Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...

Over the past year, the Rapid City Rush have had their share of battles when it comes to cancer. Which is why their Rush ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...

Disorders like esophageal cancer and gastroesophageal reflux disease are difficult to treat without properly understanding the esophagus’s mechanical properties. The findings establish a baseline for ...

These changes are typically caused by gastroesophageal reflux disease, or chronic heartburn, and can lead to esophageal cancer. Acid reflux happening repeatedly over time can cause ...

MONROE, La. (KNOE) - The Monroe Fire Department has finished its three-day esophageal cancer screening event for its ...

Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid's EsoGuard Esophageal DNA Test, as an acceptable alternative to endoscopy "This update is an important ...

Lucid Diagnostics Inc.�(Nasdaq: LUCD)�("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, a ...